Naloxone: Policies and Access
Policies have helped make naloxone more available, thus contributing to the reduction of opioid-related deaths in the U.S.
The infants of women taking opioids concomitantly with psychotropic medications were found to have a substantially heightened risk of neonatal drug withdrawal.
The extended-release formulation of tramadol was shown to be as effective as buprenorphine and more effective than clonidine for treating symptoms of opioid withdrawal.
While opioid abuse among young adults had decreased, abuse rates in adults 50 years and older has doubled, from 1.1 to 2.0%.